BIO CRYST Trademark

Trademark Overview


On Tuesday, January 9, 2018, a trademark application was filed for BIO CRYST with the United States Patent and Trademark Office. The USPTO has given the BIO CRYST trademark a serial number of 87748718. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, December 19, 2024. This trademark is owned by BioCryst Pharmaceuticals, Inc.. The BIO CRYST trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and drug development; medical and scientific research, namely, conducting clinical trials for others; development of pharmaceuticals for the treatment of infectious, viral, inflammatory, immunological, autoimmune and cardiovascular diseases and disorders; development of pharmaceuticals for the treatment of cancer, namely, cancers of the immune system such as T-cell and B-cell leukemias and lymphomas; development of pharmaceuticals for the treatment of influenza, AIDS, SARS, Ebola, Zika, and West Nile virus; development of pharmaceuticals for the treatment of hereditary angioedema, inflammatory bowel diseases, inflammatory connective tissue diseases and inflammatory skin diseases

General Information


Serial Number87748718
Word MarkBIO CRYST
Filing DateTuesday, January 9, 2018
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, December 19, 2024
Registration Number5549799
Registration DateTuesday, August 28, 2018
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 12, 2018

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of a stylized shaded diamond with the left and right corners rounded inward and connected by an unshaded line extending from the midpoint of each curved edge, with several unshaded circles contained inside the diamond at the top and bottom corners and the stylized wording "BIO" positioned adjacent to the left rounded edge and the word "CRYST" positioned adjacent to the right rounded edge.
Goods and ServicesPharmaceutical research and drug development; medical and scientific research, namely, conducting clinical trials for others; development of pharmaceuticals for the treatment of infectious, viral, inflammatory, immunological, autoimmune and cardiovascular diseases and disorders; development of pharmaceuticals for the treatment of cancer, namely, cancers of the immune system such as T-cell and B-cell leukemias and lymphomas; development of pharmaceuticals for the treatment of influenza, AIDS, SARS, Ebola, Zika, and West Nile virus; development of pharmaceuticals for the treatment of hereditary angioedema, inflammatory bowel diseases, inflammatory connective tissue diseases and inflammatory skin diseases

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 23, 2018
Primary Code042
First Use Anywhere DateMonday, January 8, 2018
First Use In Commerce DateMonday, January 8, 2018

Trademark Owner History


Party NameBioCryst Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDurham, NC 27703

Party NameBioCryst Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDurham, NC 27703

Party NameBioCryst Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDurham, NC 27703

Trademark Events


Event DateEvent Description
Friday, January 12, 2018NEW APPLICATION ENTERED
Tuesday, January 23, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 24, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, April 13, 2018ASSIGNED TO EXAMINER
Monday, April 16, 2018EXAMINERS AMENDMENT -WRITTEN
Monday, April 16, 2018EXAMINERS AMENDMENT E-MAILED
Monday, April 16, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, April 16, 2018EXAMINER'S AMENDMENT ENTERED
Thursday, April 26, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 3, 2018ASSIGNED TO LIE
Wednesday, May 23, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 12, 2018PUBLISHED FOR OPPOSITION
Tuesday, June 12, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, July 12, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 28, 2018REGISTERED-PRINCIPAL REGISTER
Friday, April 16, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, April 16, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 16, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 16, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 16, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, May 6, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 6, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 6, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 21, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 21, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 21, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 3, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, August 28, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, July 18, 2024TEAS SECTION 8 & 15 RECEIVED
Thursday, December 19, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, December 19, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, December 19, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, December 2, 2025ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, December 3, 2025ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY